In this study, we preliminarily confirmed that co-administration of L. gasseri KBL697 and IFX, a commercialized TNF-α inhibitor, can significantly alleviate colitis symptoms in the DSS-induced colitis mouse model. The gene discussed is TNF; the disease is colitis.